au.\*:("SCHECHTER, P. J")
Results 1 to 25 of 26
Selection :
Chemotherapeutic implications of polyamine biosynthesis inhibitionSJOERDSMA, A; SCHECHTER, P. J.Clinical pharmacology and therapeutics. 1984, Vol 35, Num 3, pp 287-300, issn 0009-9236Article
Clinical relevance of measuring GABA concentrations in cerebrospinal fluidSCHECHTER, P. J; SJOERDSMA, A.Neurochemical research. 1990, Vol 15, Num 4, pp 419-423, issn 0364-3190, 5 p.Article
Difluoromethylornithine in the treatment of African trypanosomiasisSCHECHTER, P. J; SJOERDSMA, A.Parasitology today (Regular ed.). 1986, Vol 2, Num 8, pp 223-224, issn 0169-4758Article
Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitisBHOL, K. C; SCHECHTER, P. J.British journal of dermatology (1951). 2005, Vol 152, Num 6, pp 1235-1242, issn 0007-0963, 8 p.Article
Traitement de la tryapnosomiase humaine à Trypanosoma brucei brucei gambiense par l'alpha-difluorométhylornithine: résultats chez 7 patients = Treatment of human T.b.g. infection by α difluoromethylornithine. Results of 7 patientsTAELMAN, H; MARCELIS, L; SONNET, J et al.Bulletin de la Société de pathologie exotique. 1988, Vol 81, Num 3, pp 578-588, issn 0037-9085Conference Paper
Double-blind, placebo-controlled study of vigabratin (Gamma-vinyl GABA) in drug-resistant epilepsyLOISEAU, P; HARDENBERG, J. P; PESTRE, M et al.Epilepsia (Copenhagen). 1986, Vol 27, Num 2, pp 115-120, issn 0013-9580Article
Kinetics of fenoximone, a new cardiotonic, in healthy subjectsALKEN, R. G; BELZ, G. G; HAEGELE, K. D et al.Clinical pharmacology and therapeutics. 1984, Vol 36, Num 2, pp 209-216, issn 0009-9236Article
Pharmacokinetics and tolerability of intravenous trecovirsen (GEM®91), an antisense phosphorothioate oligonucleotide, in HIV-positive subjectsSERENI, D; TUBIANA, R; GOUYETTE, A et al.Journal of clinical pharmacology. 1999, Vol 39, Num 1, pp 47-54, issn 0091-2700Article
Review : normal and abnormal central nervous system GABA metabolism in childhoodJAEKEN, J; CASAER, P; HAEGELE, K. D et al.Journal of inherited metabolic disease. 1990, Vol 13, Num 6, pp 793-801, issn 0141-8955, 9 p.Article
L'alpha-difluorométhylornithine (eflornithine) dans le traitement de la trypanosomiase humaine africaine à T. gambiense au stade tardif: efficacité et tolérance. A propos de 14 cas = The α difluoromethylornithine (eflornithine) in the treatment of human african trypanosomiasis due to T. g. at the late state. Efficacity and toleranceDOUA, F; BOA, F. Y; SCHECHTER, P. J et al.Bulletin de la Société de pathologie exotique. 1988, Vol 81, Num 3, pp 589-590, issn 0037-9085Conference Paper
Decarboxylated-S-adenosylmethionine excretion: a biochemical marker of ornithine decarboxykase inhibition by α-difluoromethylornithineHAEGELE, K. D; SPLINTER, T. A. W; ROMIJN, J. C et al.Cancer research (Baltimore). 1987, Vol 47, Num 3, pp 890-895, issn 0008-5472Article
Gamma-aminobutyric acid-transaminase deficiency: a newly recognized inborn error of neurotransmitter metabolismJAEKEN, J; CASAER, P; DE COCK, P et al.Neuropediatrics. 1984, Vol 15, Num 3, pp 165-169, issn 0174-304XArticle
Pharmacokinetics of anti-human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjectsRUIWEN ZHANG; JIEMING YAN; SCHECHTER, P. J et al.Clinical pharmacology and therapeutics. 1995, Vol 58, Num 1, pp 44-53, issn 0009-9236Article
Cerebrospinal fluid parameters in healthy volunteers during serial lumbar puncturesBEN MENACHEM, E; PERSSON, L; SCHECHTER, P. J et al.Journal of neurochemistry. 1989, Vol 52, Num 2, pp 632-635, issn 0022-3042, 4 p.Article
A propos d'un cas de trypanosomiase africaine traitée en France par l'eflornithine = One case of african trypanosomiasis treated in France with eflornithineCHANDENIER, J; BENHAMOU, P. H; SCHECHTER, P. J et al.Bulletin de la Société française de parasitologie. 1988, Vol 6, Num 1, pp 7-10, issn 0761-8328Article
2-pyrrolidinone in human cerebrospinal fluid: a major constituent of total γ-aminobutyric acidHAEGELE, K. D; SCHWARTZ, J.-J; SCHOUN, J et al.Journal of neurochemistry. 1987, Vol 49, Num 5, pp 1402-1406, issn 0022-3042Article
Treatment of acute myeloid leukemia and blastic phase of chronic myeloid leukemia with combined eflornithine-alpha difluoromethylornithine and methylglyoxal-bis-guanyl hydrazone (methyl-GAG)GASTAUT, J.-A; TELL, G; SCHECHTER, P. J et al.Cancer chemotherapy and pharmacology. 1987, Vol 20, Num 4, pp 344-348, issn 0344-5704Article
Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-α-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trialVAN NIEUWENHOVE, S; SCHECHTER, P. J; DECLERCQ, J et al.Transactions of the Royal Society of Tropical Medicine and Hygiene. 1985, Vol 79, Num 5, pp 692-698, issn 0035-9203Article
Effects du gamma-vinyl GABA per os dans cinq cas de schizophrénie hébéphréno-catatonique = Effects of oral gamma-vinyl GABA in five cases of hebephreno-catatonic schizophreniaLAMBERT, P. A; CHABANNES, J. P; CANTINIAUX, P et al.L' Encéphale (Paris). 1983, Vol 9, Num 2, pp 145-149, issn 0013-7006Article
Anti-inflammatory effect of topical nanocrystalline silver cream on allergic contact dermatitis in a guinea pig modelBHOL, K. C; ALROY, J; SCHECHTER, P. J et al.Clinical and experimental dermatology (Print). 2004, Vol 29, Num 3, pp 282-287, issn 0307-6938, 6 p.Article
Utilisation de la difluorométhylornithine dans la trypanosomiase congénitale à Trypanosoma Brucei-Gambiense = Utilization of difluoromethylornithine in congenital T.b.g. trypanosomiasisPEPIN, J; GUERN, C; MILORD, F et al.Médecine tropicale. 1989, Vol 49, Num 1, pp 83-85, issn 0025-682XArticle
Effects of single doses of vigabatrin on CSF concentrations of GABA, homocarnosine, homovanillic acid and 5-hydroxyindoleacetic acid in patients with complex partial epilepsyBEN MENACHEM, E; PERSSON, L. I; SCHECHTER, P. J et al.Epilepsy research. 1988, Vol 2, Num 2, pp 96-101, issn 0920-1211Article
Difluoromethylornithine for arseno-resistant Trypanosoma brucei gambiense sleeping sicknessPEPIN, J; MILORD, F; GUERN, C et al.Lancet (British edition). 1987, Vol 2, Num 8573, pp 1431-1433, issn 0140-6736Article
Kinetics of the enantiomers of vigabatrin after an oral dose of the racemate or the active S-enantiomerHAEGELE, K. D; SCHECHTER, P. J.Clinical pharmacology and therapeutics. 1986, Vol 40, Num 5, pp 581-586, issn 0009-9236Article
α-Difluoromethylornithine induces protective immunity in mice inoculated with Plasmodium berghei sporozoitesGILLET, J; BONE, G; LOWA, P et al.Transactions of the Royal Society of Tropical Medicine and Hygiene. 1986, Vol 80, Num 2, pp 236-239, issn 0035-9203Article